Literature DB >> 9869579

Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis.

T M Coque1, K V Singh, G M Weinstock, B E Murray.   

Abstract

Enterococci are usually susceptible in vitro to trimethoprim; however, high-level resistance (HLR) (MICs, >1,024 microg/ml) has been reported. We studied Enterococcus faecalis DEL, for which the trimethoprim MIC was >1,024 microg/ml. No transfer of resistance was achieved by broth or filter matings. Two different genes that conferred trimethoprim resistance when they were cloned in Escherichia coli (MICs, 128 and >1,024 microg/ml) were studied. One gene that coded for a polypeptide of 165 amino acids (MIC, 128 microg/ml for E. coli) was identical to dfr homologs that we cloned from a trimethoprim-susceptible E. faecalis strain, and it is presumed to be the intrinsic E. faecalis dfr gene (which causes resistance in E. coli when cloned in multiple copies); this gene was designated dfrE. The nucleotide sequence 5' to this dfr gene showed similarity to thymidylate synthetase genes, suggesting that the dfr and thy genes from E. faecalis are located in tandem. The E. faecalis gene that conferred HLR to trimethoprim in E. coli, designated dfrF, codes for a predicted polypeptide of 165 amino acids with 38 to 64% similarity with other dihydrofolate reductases from gram-positive and gram-negative organisms. The nucleotide sequence 5' to dfrF did not show similarity to the thy sequences. A DNA probe for dfrF hybridized under high-stringency conditions only to colony lysates of enterococci for which the trimethoprim MIC was >1,024 microg/ml; there was no hybridization to plasmid DNA from the strain of origin. To confirm that this gene causes trimethoprim resistance in enterococci, we cloned it into the integrative vector pAT113 and electroporated it into RH110 (E. faecalis OG1RF::Tn916DeltaEm) (trimethoprim MIC, 0.5 microg/ml), which resulted in RH110 derivatives for which the trimethoprim MIC was >1, 024 microg/ml. These results indicate that dfrF is an acquired but probably chromosomally located gene which is responsible for in vitro HLR to trimethoprim in E. faecalis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869579      PMCID: PMC89034     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  49 in total

1.  Conjugal transfer of plasmid DNA from Escherichia coli to enterococci: a method to make insertion mutations.

Authors:  F Teng; B E Murray; G M Weinstock
Journal:  Plasmid       Date:  1998       Impact factor: 3.466

Review 2.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Cloning, sequencing, and expression of the Lactobacillus casei thymidylate synthase gene.

Authors:  K Pinter; V J Davisson; D V Santi
Journal:  DNA       Date:  1988-05

4.  Nucleotide sequence of the thymidylate synthase B and dihydrofolate reductase genes contained in one Bacillus subtilis operon.

Authors:  M Iwakura; M Kawata; K Tsuda; T Tanaka
Journal:  Gene       Date:  1988-04-15       Impact factor: 3.688

5.  Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257.

Authors:  D A Rouch; L J Messerotti; L S Loo; C A Jackson; R A Skurray
Journal:  Mol Microbiol       Date:  1989-02       Impact factor: 3.501

6.  Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

7.  Trimethoprim resistance in enterococci: microbiological and biochemical aspects.

Authors:  J M Hamilton-Miller; S Stewart
Journal:  Microbios       Date:  1988

8.  Tn916 delta E: a Tn916 transposon derivative expressing erythromycin resistance.

Authors:  C E Rubens; L M Heggen
Journal:  Plasmid       Date:  1988-09       Impact factor: 3.466

9.  Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement.

Authors:  E E Howell; P G Foster; L M Foster
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

10.  One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution.

Authors:  C T Chung; S L Niemela; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  19 in total

1.  Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.

Authors:  Christina R Bourne; Nancy Wakeham; Baskar Nammalwar; Vladimir Tseitin; Philip C Bourne; Esther W Barrow; Shankari Mylvaganam; Kal Ramnarayan; Richard A Bunce; K Darrell Berlin; William W Barrow
Journal:  Biochim Biophys Acta       Date:  2012-09-20

2.  Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.

Authors:  H Mehta; J Weng; A Prater; R A L Elworth; X Han; Y Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

3.  Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.

Authors:  Esther W Barrow; Philip C Bourne; William W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454).

Authors:  Jun-ichiro Sekiguchi; Prasit Tharavichitkul; Tohru Miyoshi-Akiyama; Vena Chupia; Tomoko Fujino; Minako Araake; Atsushi Irie; Koji Morita; Tadatoshi Kuratsuji; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Factors that cause trimethoprim resistance in Streptococcus pyogenes.

Authors:  René Bergmann; Mark van der Linden; Gursharan S Chhatwal; D Patric Nitsche-Schmitz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

6.  In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs.

Authors:  Patrick Caspers; Luc Bury; Bérangère Gaucher; Jutta Heim; Stuart Shapiro; Sibylle Siegrist; Anne Schmitt-Hoffmann; Laure Thenoz; Heinrich Urwyler
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

7.  Reduced susceptibility of Moritella profunda dihydrofolate reductase to trimethoprim is not due to glutamate 28.

Authors:  E Joel Loveridge; William M Dawson; Rhiannon M Evans; Anna Sobolewska; Rudolf K Allemann
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

8.  Sponge Microbiota Are a Reservoir of Functional Antibiotic Resistance Genes.

Authors:  Dennis Versluis; Mari Rodriguez de Evgrafov; Morten O A Sommer; Detmer Sipkema; Hauke Smidt; Mark W J van Passel
Journal:  Front Microbiol       Date:  2016-11-17       Impact factor: 5.640

9.  A global to local genomics analysis of Clostridioides difficile ST1/RT027 identifies cryptic transmission events in a northern Arizona healthcare network.

Authors:  Charles H D Williamson; Nathan E Stone; Amalee E Nunnally; Heidie M Hornstra; David M Wagner; Chandler C Roe; Adam J Vazquez; Nivedita Nandurkar; Jacob Vinocur; Joel Terriquez; John Gillece; Jason Travis; Darrin Lemmer; Paul Keim; Jason W Sahl
Journal:  Microb Genom       Date:  2019-05-20

10.  The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor docking.

Authors:  Christina R Bourne; Nancy Wakeham; Nicole Webb; Baskar Nammalwar; Richard A Bunce; K Darrell Berlin; William W Barrow
Journal:  Biochemistry       Date:  2014-02-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.